172 related articles for article (PubMed ID: 9461033)
1. Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity.
Hyder SM; Chiappetta C; Stancel GM
Cancer Lett; 1997 Dec; 120(2):165-71. PubMed ID: 9461033
[TBL] [Abstract][Full Text] [Related]
2. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen.
Hyder SM; Stancel GM; Chiappetta C; Murthy L; Boettger-Tong HL; Makela S
Cancer Res; 1996 Sep; 56(17):3954-60. PubMed ID: 8752163
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780.
Hyder SM; Chiappetta C; Murthy L; Stancel GM
Cancer Res; 1997 Jul; 57(13):2547-9. PubMed ID: 9205050
[TBL] [Abstract][Full Text] [Related]
4. Time-related effects of a triphenylethylene antiestrogen on estrogen-induced changes in uterine weight, estrogen receptors, and endometrial sensitivity in rats.
Trivedi RN; Chauhan SC; Dwivedi A; Kamboj VP; Singh MM
Contraception; 1995 Jun; 51(6):367-79. PubMed ID: 7554978
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
[TBL] [Abstract][Full Text] [Related]
6. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
[TBL] [Abstract][Full Text] [Related]
7. In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer.
Takei H; Lee ES; Jordan VC
Breast Cancer; 2002; 9(1):39-42. PubMed ID: 12196720
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens.
Branham WS; Zehr DR; Sheehan DM
Proc Soc Exp Biol Med; 1993 Jul; 203(3):297-303. PubMed ID: 8516342
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus.
Kirkland JL; Murthy L; Stancel GM
Mol Pharmacol; 1993 May; 43(5):709-14. PubMed ID: 8502228
[TBL] [Abstract][Full Text] [Related]
10. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
11. Disparate effects of triphenylethylene antiestrogens on estrogen and progestin biosyntheses by cultured rat granulosa cells.
Welsh TH; Jia XC; Jones PB; Zhuang LZ; Hsueh AJ
Endocrinology; 1984 Oct; 115(4):1275-82. PubMed ID: 6434288
[TBL] [Abstract][Full Text] [Related]
12. Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone.
Hyder SM; Chiappetta C; Stancel GM
Cancer Lett; 2000 Aug; 156(1):101-7. PubMed ID: 10840165
[TBL] [Abstract][Full Text] [Related]
13. Regulation of vascular endothelial growth factor expression by estrogens and progestins.
Hyder SM; Huang JC; Nawaz Z; Boettger-Tong H; Mäkelä S; Chiappetta C; Stancel GM
Environ Health Perspect; 2000 Oct; 108 Suppl 5():785-90. PubMed ID: 11035983
[TBL] [Abstract][Full Text] [Related]
14. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
Sato M; Rippy MK; Bryant HU
FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens.
Barrera G; Screpanti I; Paradisi L; Parola M; Ferretti C; Vacca A; Farina A; Dianzani MU; Frati L; Gulino A
Biochem Pharmacol; 1986 Sep; 35(17):2984-6. PubMed ID: 3017367
[No Abstract] [Full Text] [Related]
16. Inhibition of angiogenesis by antiestrogens.
Gagliardi A; Collins DC
Cancer Res; 1993 Feb; 53(3):533-5. PubMed ID: 7678775
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth.
Cullinan-Bove K; Koos RD
Endocrinology; 1993 Aug; 133(2):829-37. PubMed ID: 8344219
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus.
Reed CA; Berndtson AK; Nephew KP
Anticancer Drugs; 2005 Jun; 16(5):559-67. PubMed ID: 15846122
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in the rat pituitary: differential distribution and regulation by estrogen.
Ochoa AL; Mitchner NA; Paynter CD; Morris RE; Ben-Jonathan N
J Endocrinol; 2000 May; 165(2):483-92. PubMed ID: 10810312
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors.
Gagliardi AR; Hennig B; Collins DC
Anticancer Res; 1996; 16(3A):1101-6. PubMed ID: 8702220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
